Chan et al. [39] conducted an immunohistochemistry analysis on 104 cases with non-small cell lung cancer and displayed that PSAT1 level in tumor tissue is higher than that in adjacent normal tissue, and increased PSAT1 is implicated in unfavorable prognosis of patients with early adenocarcinoma. Here, PSAT1 is linked to adenocarcinoma.